Sponsors

Organizers:

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.

In 2008, Roche had over 80’000 employees worldwide and invested almost 9 billion Swiss francs in R&D.

The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan.

For more information: www.roche.com

OrbiMed

OrbiMed is the world’s largest healthcare and life sciences-dedicated investment firm, with approximately $5 billion in assets under management. Since inception of its private equity investment activities in 1993, OrbiMed has successfully invested in over 100 private companies across a wide range of therapeutic categories and stages of development. OrbiMed’s investment team includes over 30 experienced professionals with backgrounds in science, medicine, industry, finance and law. OrbiMed launched the first pan-Asia healthcare and life sciences-dedicated venture capital fund in 2008, with close to $200 million in commitments. OrbiMed maintains offices in New York City, Shanghai, Mumbai and San Francisco.

For more information: www.OrbiMed.com

McKinsey & Company in Greater China

With over 8,000 consultants deployed from over 90 offices in 50 countries, McKinsey & Company is a global management consulting firm that advises companies and public institutions on issues concerning strategy, organization, operations, and technology. McKinsey's Greater China Practice comprises offices in Beijing, Hong Kong, Shanghai and Taipei. McKinsey has completed more than 1,000 projects in Greater China in the past two decades, helping leading local enterprises boost their global competitiveness, as well as assisting multinational companies seeking to expand their business in the region. www.china.mckinsey.com

Presenter:

ChinaBio® LLC

ChinaBio® Accelerator was created to accelerate the globalization of China's biotechnology industry by:

• Providing early stage funding to China life science companies;
  
• Increasing China entrepreneurs’ success rate by mentoring and providing strategic support;
• Developing business partnership and sales development opportunities with the West; and
• Expanding professional networks through introductions to investors, partners, customers and media.

ChinaBio is identifying promising biotech and medical device investment opportunities in China and providing the capital, connections and leadership to help entrepreneurs realize their vision. www.ChinaBioLLC.com